The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Iveco Group NV
MIL:IVG
|
IT |
|
R
|
Retailors Ltd
TASE:RTLS
|
IL |
|
Merck KGaA
F:MRKC
|
DE |
|
A
|
American Express Co
SGO:AXP
|
US |
|
H
|
Helen of Troy Ltd
F:HT2
|
BM |
|
M
|
Merck KGaA
F:MRK
|
DE |
|
J
|
Jefferson Capital Inc
NASDAQ:JCAP
|
US |
|
C
|
CVS Health Corp
SWB:CVS
|
US |
|
Altisource Asset Management Corp
OTC:AAMCF
|
VI |
|
C
|
China Merchants Port Holdings Co Ltd
SWB:CPM
|
HK |
|
Affirm Holdings Inc
NASDAQ:AFRM
|
US |
|
Oncosil Medical Ltd
ASX:OSL
|
AU |
|
Logitech international SA
SIX:LOGN
|
CH |
|
Goldman Sachs BDC Inc
NYSE:GSBD
|
US |
|
L
|
Lloyds Banking Group PLC
XMUN:LLD
|
UK |
|
Lands' End Inc
NASDAQ:LE
|
US |
|
S
|
St Augustine Gold and Copper Ltd
OTC:RTLGF
|
SG |
|
C
|
Central Japan Railway Co
OTC:CJPRY
|
JP |
|
C
|
Compagnie de Saint Gobain SA
DUS:GOB
|
FR |
|
T
|
Tectona Ltd
TASE:TECT
|
IL |
|
Naspers Ltd
F:NNW
|
ZA |
|
V
|
ViacomCBS Inc
F:0VV
|
US |
|
O
|
OFS Capital Corp
F:9UD
|
US |
|
T
|
Thaitheparos PCL
SET:SAUCE
|
TH |
Iveco Group NV (IVG)’s 12-month stock price forecast through October 2027 has a consensus target of €14.688, implying 2% upside. The forecast is based on price targets from 8 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
IVG is 14.688 EUR with a low forecast of 14.16 EUR and a high forecast of 20.895 EUR.
Over the last 6 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 6%.
Over the last 6 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 3 years is 24%.
Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 37%.
Over the last 6 years, the compound annual growth rate for Net Income has been 23%. The projected CAGR for the next 3 years is 36%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more